EyeGene Inc. (KOSDAQ:185490)

EyeGene Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,933	1,425	5,496	2,046	2,649	2,723
Short-Term Investments	23,122	31,122	49,872	59,080	72,680	29,158
Trading Asset Securities	194.37	-	-	5,329	10,027	468.34
Cash & Short-Term Investments	26,249	32,547	55,368	66,455	85,357	32,349
Cash Growth	-24.71%	-41.22%	-16.68%	-22.14%	163.86%	-18.10%
Accounts Receivable	1,016	1,415	468.06	898.07	731.32	841.91
Other Receivables	-	312.04	428.64	486.97	296.1	49.91
Receivables	1,016	1,727	896.7	1,385	1,027	891.82
Inventory	466.56	584.99	55.21	498.01	774.4	704.49
Prepaid Expenses	-	149.19	240.5	-	-	-
Other Current Assets	265.52	289.3	317.01	492.77	1,485	2,172
Total Current Assets	27,997	35,298	56,877	68,830	88,644	36,117
Property, Plant & Equipment	6,519	9,315	9,851	5,742	5,864	3,549
Long-Term Investments	14,404	14,159	9,337	3,807	4,076	1,136
Other Intangible Assets	4,824	4,281	982.61	844.1	761.27	487.42
Other Long-Term Assets	2,860	2,150	1,055	1,158	5,646	3,137
Total Assets	56,604	65,306	78,103	80,381	104,991	44,427
Accounts Payable	1,156	1,680	470.69	863.84	1,894	1,530
Accrued Expenses	-	252.29	341.29	343.29	361.43	78.66
Short-Term Debt	-	1,773	1,498	1,392	2,995	5,234
Current Portion of Leases	173.52	179.6	314.49	392.85	272.63	228.49
Current Unearned Revenue	-	0.64	3.33	3.2	3.16	64.74
Other Current Liabilities	5,637	5,534	5,634	1,924	4,083	1,353
Total Current Liabilities	6,966	9,419	8,262	4,920	9,609	8,489
Long-Term Debt	-	-	-	-	-	11,516
Long-Term Leases	424.05	487.56	338.43	611.41	676.06	144.1
Pension & Post-Retirement Benefits	2,774	2,546	3,485	4,613	4,055	2,411
Long-Term Deferred Tax Liabilities	-	-	-	-	1,168	1,252
Other Long-Term Liabilities	562.28	437.83	626.99	1,281	513.64	7,716
Total Liabilities	10,727	12,891	12,713	11,426	16,022	31,528
Common Stock	13,515	13,515	13,515	10,739	10,705	5,825
Additional Paid-In Capital	188,319	188,325	188,329	176,131	176,277	70,688
Retained Earnings	-168,611	-161,740	-149,862	-129,722	-103,829	-68,053
Comprehensive Income & Other	10,497	10,221	11,248	9,580	5,816	4,440
Total Common Equity	43,720	50,321	63,230	66,728	88,969	12,899
Minority Interest	335.72	513.52	1,104	2,228	-	-
Shareholders' Equity	45,877	52,415	65,390	68,956	88,969	12,899
Total Liabilities & Equity	56,604	65,306	78,103	80,381	104,991	44,427
Total Debt	597.57	2,441	2,151	2,397	3,943	17,122
Net Cash (Debt)	25,651	30,107	53,217	64,058	81,413	15,228
Net Cash Growth	-17.05%	-43.43%	-16.92%	-21.32%	434.64%	-28.51%
Net Cash Per Share	815.70	1113.84	2458.55	2987.22	4298.37	1101.24
Filing Date Shares Outstanding	27.07	27.03	27.03	21.48	21.41	13.98
Total Common Shares Outstanding	27.07	27.03	27.03	21.48	21.41	13.98
Working Capital	21,031	25,878	48,615	63,911	79,034	27,629
Book Value Per Share	1615.16	1861.69	2339.28	3106.77	4155.60	922.76
Tangible Book Value	38,896	46,040	62,248	65,884	88,208	12,412
Tangible Book Value Per Share	1436.94	1703.31	2302.93	3067.47	4120.04	887.90
Machinery	-	13,374	13,392	7,251	6,154	4,418
Construction In Progress	-	-	-	102.83	613.25	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.